interleukin-17 receptor modulator(Immunex)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug Nameinterleukin-17 receptor modulator(Immunex)
Drug Alias NameIL-17R (Immunex)IL-17 receptor modulator(Immunex)IL-17R
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionInterleukin-17 receptors modulators
TargetsInterleukin-17 receptors
Therapy Area/IndicationsRejection of organ transplantation
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesImmunex Corp
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesImmunex Corp
Active IndicationsN/A
Inactive IndicationsRejection of organ transplantation

Other Information

ATC CodeN/A
Related LinksN/A